These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29602037)

  • 21. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
    Kamal A; Suresh P; Mallareddy A; Kumar BA; Reddy PV; Raju P; Tamboli JR; Shaik TB; Jain N; Kalivendi SV
    Bioorg Med Chem; 2011 Apr; 19(7):2349-58. PubMed ID: 21402478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
    Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
    Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
    Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
    Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
    Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS.
    Zhou M; Ji S; Wu Z; Li Y; Zheng W; Zhou H; Chen T
    Eur J Med Chem; 2015; 96():92-7. PubMed ID: 25874334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives.
    Li SY; Chen YL; Wang C; Tzeng CC
    Bioorg Med Chem; 2006 Nov; 14(22):7370-6. PubMed ID: 16887354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
    Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
    Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison.
    Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y
    Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility.
    Aceves-Luquero C; Galiana-Roselló C; Ramis G; Villalonga-Planells R; García-España E; Fernández de Mattos S; Peláez R; Llinares JM; González-Rosende ME; Villalonga P
    Biochem Pharmacol; 2016 Sep; 115():28-42. PubMed ID: 27349984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization, antitumor activity and safety testing of novel polyphosphoesters bearing anthracene-derived aminophosphonate units.
    Kraicheva I; Vodenicharova E; Shenkov S; Tashev E; Tosheva T; Tsacheva I; Kril A; Topashka-Ancheva M; Georgieva A; Iliev I; Vladov I; Gerasimova Ts; Troev K
    Bioorg Med Chem; 2014 Jan; 22(2):874-82. PubMed ID: 24365391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
    Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
    Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
    Liang Y; Zhou Y; Deng S; Chen T
    ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents.
    Vogel S; Kaufmann D; Pojarová M; Müller C; Pfaller T; Kühne S; Bednarski PJ; von Angerer E
    Bioorg Med Chem; 2008 Jun; 16(12):6436-47. PubMed ID: 18513974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
    Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
    Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
    J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KSP inhibitors as antimitotic agents.
    Pérez-Melero C
    Curr Top Med Chem; 2014; 14(20):2286-311. PubMed ID: 25434354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
    Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
    Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.